Conflicts and contradictions in current skin cancer screening guidelines

Area of Science:

• Dermatology
• Public Health
• Evidence-Based Medicine

Background:

• Skin cancer is a significant public health concern.
• Current guidelines for skin cancer screening lack consensus among major health organizations.
• The efficacy of skin cancer screening remains debated, particularly for non-melanoma skin cancers (NMSC).

Purpose of the Study:

• To review existing skin cancer screening guidelines from prominent public health and medical organizations.
• To identify areas of consensus and divergence in current screening recommendations.
• To evaluate the evidence base supporting skin cancer screening strategies.

Main Methods:

• Systematic review of guidelines from major public health and medical organizations.
• Analysis of the evidence supporting recommendations for skin cancer screening.
• Consideration of the limitations in current research, such as the lack of population-based randomized trials.

Main Results:

• There is a notable lack of consensus regarding the necessity and efficacy of skin cancer screening.
• Current guidelines predominantly focus on melanoma, often overlooking potential benefits of screening for non-melanoma skin cancers (NMSC).
• Evidence from population-based randomized trials is scarce due to feasibility constraints.

Conclusions:

• Consensus on skin cancer screening should be built upon observational and non-randomized study designs, such as the SCREEN study.
• Including both melanoma and NMSC in screening considerations may strengthen the case for screening.
• Targeted screening approaches for high-risk populations require further definition and testing to improve clarity and reduce confusion.
• Current recommendations highlighting insufficient evidence hinder effective screening implementation and may not adequately address melanoma mortality or NMSC morbidity.